Overview
Inventia Life Science develops advanced 3D cell culture and bioprinting solutions, including the RASTRUM platform, to generate reproducible, biologically relevant in vitro models for drug discovery. They offer RASTRUM Validated Solutions with predefined model blueprints for applications like pancreatic ductal adenocarcinoma and fibroblast activation, enabling decision-grade data from human-relevant 3D models. Through Inventia Discovery Services, they partner with biopharma teams to build indication-specific models in oncology, fibrosis, neurology, and immunology.
Frequently asked questions
- What 3D bioprinting platforms does Inventia Life Science offer?
- Inventia offers the RASTRUM bioprinting platform for high-throughput production of complex, multi-cellular 3D models, including RASTRUM Validated Solutions for reproducible drug response studies in tumor-stromal interactions.
- What therapeutic areas does Inventia support with their models?
- They specialize in indication-specific 3D cell models across oncology (e.g., PDAC), fibrosis, neurology, and immunology to improve preclinical study predictivity.
- Where are Inventia Life Science's locations?
- Inventia has facilities in Sydney, Australia (Alexandria and Collins Street), and Wilmington, Delaware, United States, supporting biopharma partnerships globally.